Home > Ophthotech Salary

Ophthotech Salary

  • 32
  • 48
  • 84
Ophthotech average salary is $110,500, median salary is $110,500 with a salary range from $110,000 to $111,000.
Ophthotech salaries are collected from government agencies and companies. Each salary is associated with a real job position. Ophthotech salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
110,000
Average
110,500
Median
110,500
High
111,000
Total 1 Ophthotech Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Project Controls Engineer 110,000-111,000 San Antonio, TX, 78201 2016 Ophthotech Project Controls Engineer Salaries (2)
Ophthotech San Antonio, TX Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Ophthotech salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Ophthotech Jobs
See more Ophthotech Jobs»
Search All Jobs

JobsOpenHiring – Find open jobs faster
Ophthotech... Information
  • Ophthotech Corp
  • Industry: Major Drugs
  • City: Princeton, NJ
  • Ophthotech Corp. is a privately held biopharmaceutical company focused on developing and commercializing therapies for back-of-the-eye diseases. Ophthotech plans to develop a pipeline of compounds with strong scientific foundations for the treatment of AMD and bring them to market in an accelerated manner. In August of 2007, Ophthotech announced a Series A venture financing and two separate in-licensing deals with Archemix Corp. and (OSI) Eyetech. A third in-license from Biogen Idec and PDL BioPharma was announced in January of 2008. Ophthotech's venture investors include SV Life Sciences, HBM BioVentures and Novo A/S. For more information, please visit http://www.ophthotech.com.